{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:20:46Z","timestamp":1759033246983,"version":"3.35.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.bbr.2008.11.011","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T11:23:54Z","timestamp":1227007434000},"page":"359-365","source":"Crossref","is-referenced-by-count":22,"title":["Sibutramine-induced anorexia: Potent, dose-dependent and behaviourally-selective profile in male rats"],"prefix":"10.1016","volume":"198","author":[{"given":"A.J.","family":"Tallett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2008.11.011_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tips.2008.01.008","article-title":"Anti-obesity drugs and neural circuits of feeding","volume":"29","author":"Adan","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bbr.2008.11.011_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/h0077040","article-title":"Cholecystokinin elicits the complete behavioral sequence of satiety in rats","volume":"89","author":"Antin","year":"1975","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.bbr.2008.11.011_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00023210-199809060-00005","article-title":"Serotonin and appetite regulation: implications for the treatment of obesity","volume":"9","author":"Blundell","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2008.11.011_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0091-3057(80)90155-0","article-title":"Characteristic adjustments to the structure of feeding behaviour following pharmacological treatments: effects of amphetamine and fenfluramine and the antagonism by pimozide and metergoline","volume":"12","author":"Blundell","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0361-9230(85)90004-8","article-title":"Behavioural structure and mechanisms of anorexia: calibration of normal and abnormal inhibition of eating","volume":"15","author":"Blundell","year":"1985","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2008.11.011_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1124\/pr.59.2.2","article-title":"Pharmacological treatment of the overweight patient","volume":"59","author":"Bray","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bbr.2008.11.011_bib7","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/sj.bjp.0704030","article-title":"Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y","volume":"132","author":"Brown","year":"2001","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/1028415031000094264","article-title":"Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins","volume":"6","author":"Casado","year":"2003","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.bbr.2008.11.011_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00443419","article-title":"A behavioural profile of fluoxetine-induced anorexia","volume":"97","author":"Clifton","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2008.11.011_bib10","first-page":"388P","article-title":"A study in rats of the effects of sibutramine on food intake and thermogenesis","volume":"114","author":"Connoley","year":"1995","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib11","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/sj.bjp.0702446","article-title":"Thermogenic effects of sibutramine and its metabolites","volume":"126","author":"Connoley","year":"1999","journal-title":"Brit J Pharmacol"},{"issue":"Suppl. 2","key":"10.1016\/j.bbr.2008.11.011_bib12","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1038\/sj.ijo.0801297","article-title":"Effect of sibutramine on glucose metabolism in genetically obese (fa\/fa) Zucker rats","volume":"24","author":"Fabris","year":"2000","journal-title":"Int J Obesity"},{"issue":"Suppl. 2","key":"10.1016\/j.bbr.2008.11.011_bib13","first-page":"145","article-title":"Effects of metabolites 1 and 2 of sibutramine on the shirt-term control of food intake in the rat","volume":"19","author":"Fantino","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.bbr.2008.11.011_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0091-3057(93)90269-Y","article-title":"Bray GA. d-fenfluramine in a rat model of dietary fat-induced obesity","volume":"45","author":"Fisler","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.physbeh.2005.10.014","article-title":"Effects of sibutramine on the appetitive and consummatory aspects of feeding in non-human primates","volume":"87","author":"Foltin","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-2999(93)90013-8","article-title":"d-Fenfluramine and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors","volume":"242","author":"Gibson","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pbb.2006.03.014","article-title":"Locomotion is the major determinant of sibutramine-induced increase in energy expenditure","volume":"83","author":"Golozoubova","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.bjp.0702633","article-title":"Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats","volume":"127","author":"Grignaschi","year":"1999","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)37090-9","article-title":"In vivo criteria to differentiate monoamine re-uptake inhibitors from releasing agents: sibutramine is a re-uptake inhibitor","volume":"283","author":"Gundlah","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2008.11.011_bib20","first-page":"95P","article-title":"5-Hydroxytryptaminergic drugs compared on the behavioural sequence associated with satiety","volume":"100","author":"Halford","year":"1993","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1568015033477695","article-title":"The psychopharmacology of appetite: targets for potential anti-obesity agents","volume":"3","author":"Halford","year":"2003","journal-title":"Curr Med Chem: CNS Agents"},{"key":"10.1016\/j.bbr.2008.11.011_bib22","first-page":"387P","article-title":"Effects in the rat of sibutramine on food intake and the behavioural satiety sequence","volume":"114","author":"Halford","year":"1995","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0091-3057(98)00032-X","article-title":"Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake","volume":"61","author":"Halford","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib24","first-page":"S18","article-title":"Sibutramine: a novel anti-obesity drug: a review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine","volume":"22","author":"Heal","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.bbr.2008.11.011_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.physbeh.2004.01.009","article-title":"Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats","volume":"81","author":"Ishii","year":"2004","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib26","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","article-title":"Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib27","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/sj.bjp.0701312","article-title":"Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib28","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s002130000596","article-title":"Synergistic effects of opioid and cannabinoid antagonists on food intake","volume":"153","author":"Kirkham","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2008.11.011_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0091-3057(99)00044-1","article-title":"Feeding and reward interactions from chronic paroxetine treatment","volume":"63","author":"Konkle","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0091-3057(03)00021-2","article-title":"Chronic paroxetine infusion influences macronutrient selection in male Sprague-Dawley rats","volume":"74","author":"Konkle","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.physbeh.2003.07.010","article-title":"Effect of sibutramine on macronutrient selection in male and female rats","volume":"80","author":"LeBlanc","year":"2003","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1345\/aph.18319","article-title":"Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity","volume":"33","author":"Luque","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bbr.2008.11.011_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(02)01423-1","article-title":"The discovery and status of sibutramine as an anti-obesity drug","volume":"440","author":"Luque","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0022-3565(24)36713-8","article-title":"Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drug","volume":"281","author":"McCann","year":"1997","journal-title":"J Pharmacol Exper Ther"},{"key":"10.1016\/j.bbr.2008.11.011_bib35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0091-3057(92)90230-D","article-title":"Effects of the 5-HT uptake inhibitors, femoxetine and paroxetine, and a 5-HT1A\/B agonist, eltoprazine, on the behavioural satiety sequence","volume":"41","author":"McGuirk","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02245426","article-title":"Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence","volume":"106","author":"McGuirk","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2008.11.011_bib37","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"A review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.bbr.2008.11.011_bib38","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1093\/ajcn\/55.1.185s","article-title":"Sertraline, a serotonin-uptake inhibitor, reduces food intake and body weight in lean rats and genetically obese mice","volume":"55","author":"Nielsen","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bbr.2008.11.011_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1467-789x.2000.00020.x","article-title":"An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action","volume":"1","author":"Nisoli","year":"2000","journal-title":"Obesity Revs"},{"key":"10.1016\/j.bbr.2008.11.011_bib40","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.0953-816x.2001.01518.x","article-title":"SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats","volume":"13","author":"Rodgers","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2008.11.011_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0301-0082(86)90011-0","article-title":"Neurobiology of an anorectic drug: Fenfluramine","volume":"27","author":"Rowland","year":"1986","journal-title":"Progr Neurobiol"},{"key":"10.1016\/j.bbr.2008.11.011_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-4328(96)00066-6","article-title":"Serotonergic control of the organization of feeding and satiety","volume":"73","author":"Simansky","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2008.11.011_bib43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0361-9230(90)90194-5","article-title":"Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists","volume":"25","author":"Simansky","year":"1990","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2008.11.011_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/oby.2002.27","article-title":"Regulation of body weight and carcass composition by sibutramine in rats","volume":"10","author":"Strack","year":"2002","journal-title":"Obesity Res"},{"issue":"145","key":"10.1016\/j.bbr.2008.11.011_bib45","first-page":"P398","article-title":"Effects of sibutramine on feeding behaviour in dietary-induced obesity: role of dietary constituents","volume":"19","author":"Stricker-Kongrad","year":"1995","journal-title":"Int J Obes"},{"issue":"145","key":"10.1016\/j.bbr.2008.11.011_bib46","first-page":"P399","article-title":"Effects of sibutramine on feeding behaviour in obese and lean Zucker rats","volume":"19","author":"Stricker-Kongrad","year":"1995","journal-title":"Int J Obes"},{"key":"10.1016\/j.bbr.2008.11.011_bib47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FBP.0b013e3282eff0a9","article-title":"Acute anorectic response to cannabinoid receptor antagonist\/inverse agonist AM 251 in rat: indirect behavioural mediation","volume":"18","author":"Tallett","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2008.11.011_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-007-0880-2","article-title":"Rodgers RJ Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats","volume":"195","author":"Tallett","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2008.11.011_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bbr.2007.10.005","article-title":"Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food","volume":"187","author":"Tallett","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2008.11.011_bib50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.physbeh.2008.02.009","article-title":"Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching","volume":"94","author":"Tallett","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib51","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pbb.2008.08.007","article-title":"Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats","volume":"91","author":"Tallett","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib52","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2174\/092986706778201512","article-title":"Therapeutic potential of targeting the endocannabinoids: implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation","volume":"13","author":"Tucci","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bbr.2008.11.011_bib53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.physbeh.2007.11.012","article-title":"Therapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome","volume":"93","author":"Vemuri","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib54","series-title":"Appetite and body weight. Integrative systems and the development of antiobesity drugs","first-page":"323","article-title":"Preclinical developments in antiobesity drugs","author":"Vickers","year":"2007"},{"key":"10.1016\/j.bbr.2008.11.011_bib55","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-002-1378-6","article-title":"Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia","volume":"167","author":"Vickers","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2008.11.011_bib56","unstructured":"Weiss SM. Pharmacological and behavioural examination of the defensive reactions of laboratory mice to the calls of the Tawny Owl. PhD thesis, University of Leeds; 1995."},{"key":"10.1016\/j.bbr.2008.11.011_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0091-3057(03)00045-5","article-title":"Effects of preexposure to dexfenfluramine, phenteramine, dexfenfluramine-phenteramine, or fluoxetine on sibutramine-induced hypophagia in the adult rats","volume":"75","author":"Wellman","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.11.011_bib58","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.ijo.0801729","article-title":"The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotrophin-releasing hormone","volume":"25","author":"Wieczorek","year":"2001","journal-title":"Int J Obes"},{"key":"10.1016\/j.bbr.2008.11.011_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ddr.430100106","article-title":"Reduction of food consumption and body weight of normal and obese mice by chronic treatment with fluoxetine: a serotonin reuptake inhibitor","volume":"10","author":"Yen","year":"1987","journal-title":"Drug Dev Res"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432808006293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432808006293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T20:47:34Z","timestamp":1738529254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432808006293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0166432808006293"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2008.11.011","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}